Moderna (MRNA)
(Delayed Data from NSDQ)
$24.84 USD
+0.96 (4.02%)
Updated Sep 16, 2025 04:00 PM ET
Pre-Market: $24.98 +0.14 (0.56%) 9:26 AM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Moderna, Inc. has a PEG ratio of 1.16 compared to the Medical - Biomedical and Genetics industry's PEG ratio of 1.32.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MRNA 24.84 +0.96(4.02%)
Will MRNA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MRNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MRNA
Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon?
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
MRNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Moderna (MRNA) Declines More Than Market: Some Information for Investors
Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?
Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day
Other News for MRNA
Is MRNA showing upside potential? Directional Movement Crossover Bullish shows up after climbing 4.02%
VOO ETF News, 9/17/2025
SPY ETF News, 9/17/2025
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today